Mn Services Vermogensbeheer B.V. Has $33.18 Million Position in CME Group Inc. (NASDAQ:CME)

Mn Services Vermogensbeheer B.V. raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 142,879 shares of the financial services provider’s stock after purchasing an additional 4,100 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in CME Group were worth $33,181,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Truvestments Capital LLC bought a new position in shares of CME Group in the 3rd quarter valued at about $26,000. SJS Investment Consulting Inc. raised its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the last quarter. Dunhill Financial LLC increased its holdings in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the last quarter. Financial Life Planners acquired a new position in shares of CME Group in the fourth quarter valued at $32,000. Finally, Fortitude Family Office LLC increased its holdings in shares of CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $247.99 on Thursday. The firm has a fifty day moving average of $237.86 and a 200-day moving average of $228.44. The firm has a market capitalization of $89.37 billion, a P/E ratio of 25.65, a PEG ratio of 6.76 and a beta of 0.57. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $253.53. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group declared that its board has approved a share buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 2.02%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is currently 51.71%.

Insider Activity

In other news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently commented on CME shares. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Barclays raised their price objective on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Royal Bank of Canada upped their price target on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. boosted their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research report on Thursday, February 13th. Finally, Oppenheimer lifted their price objective on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $236.13.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.